Abstract:Objective: Cardiovascular complications associated with COVID‐19 are being increasingly recognized. They include potential long‐term effects on the heart, although how these complications manifest in patients with stroke who are already vulnerable to cardiovascular issues is lacking. This study addressed this gap by investigating the influence of SARS‐CoV‐2 infection on cardiac hemodynamic changes in inpatients with stroke, thereby providing valuable insights into the management of cardiac complications in this population. Methods: This retrospective cohort study enrolled inpatients with stroke who did or did not experience SARS‐CoV‐2 infection in Shenzhen Second People's Hospital. Clinical information, hemodynamics data, serum myocardial enzyme levels, functional levels, including Barthel index, and Longshi scale assessment (bedridden, domestic, and community) were extracted from clinical records. An independent sample t‐test and the Mann–Whitney U test were used for comparison between groups. Multiple logistic regression analysis was used to identify indicators associated with decline in cardiac function in patients with stroke post‐COVID‐19. Results: Eighty‐three patients with stroke (average age of 66.0 ± 15.5 years) were recruited (42 patients in the study group and 41 in the control group). No significant difference in general characteristics was observed between the groups. The ejection fraction (EF, 56.45 ± 12.46 vs. 47.64 ± 14.76, p = 0.04) was decreased, and the end‐diastolic volume (EDV, 142.74 ± 80.00 vs. 193.34 ± 140.17, p = 0.001) was increased significantly in patients infected with SARS‐CoV‐2 compared with the noninfected participants. SARS‐CoV‐2 infection was an independent risk factor for EF (−10%) decrease (OR: 5.205, 95% CI: 1.621–16.720, p = 0.006). The risk of cardiac function decline among bedridden infected patients was 15.43 times higher than that of uninfected nonbedridden patients (OR: 15.430, 95% CI: 1.402–169.805, p = 0.025). Conclusion: Patients who are bedridden after stroke face a higher potential risk of cardiac hemodynamic impairment following SARS‐CoV‐2 infection, emphasizing the need for meticulous hemodynamic monitoring during treatment and rehabilitation of these patients to prevent any potential cardiovascular complications. Trial Registration: ClinicalTrials.gov identifier: ChiCTR2300071376.

THE SEVERITY OF NEUROLOGICAL DEFICIT IN PATIENTS WITH ISCHEMIC STROKE ON THE NIHSS SCALE DEPENDING ON THE STATUS OF COVID-19

Stroke and COVID-19: An Umbrella Review

Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19

Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report

COMPARATIVE ANALYSIS OF THE CLINICAL EFFICACY OF COMBINED NEUROPROTECTION IN PATIENTS WITH ISCHEMIC STROKE ON THE BACKGROUND OF COVID-19

Post-stroke rehabilitation in the peri-pandemic COVID-19 era

Effect of COVID-19 on Acute Ischemic Stroke Severity and Mortality in 2020: Results From the 2020 National Inpatient Sample

Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study

Neurological complications in COVID-19 - a diagnostic challenge

Bihemispheric ischemic strokes in patients with COVID-19

Management of acute ischemic stroke under routine infection prevention practices for COVID-19

Hemodynamic Alterations in Cardiac Function Among Patients With Stroke and SARS‐CoV‐2 Infection: A Retrospective Cohort Study

Impact of COVID-19 on Future Ischemic Stroke Incidence

Acute ischaemic stroke associated with SARS-CoV-2 infection in North America

Neurological and Psychological Effects of COVID-19 on Cognitive Impairment

Patterns of acute ischemic stroke and intracranial hemorrhage in patients with COVID-19 : Results of a retrospective multicenter neuroimaging-based study from three central European countries

Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes

Neurological manifestations of COVID-19: A potential gate to the determinants of a poor prognosis

Stroke Acute Management and Outcomes During the COVID-19 Outbreak: A Cohort Study From the Madrid Stroke Network.

Circulating Inflammatory Markers in COVID‐19‐Related Ischemic Stroke: A Multicenter Retrospective Analysis

The possibility of predicting the occurrence of neurological complications in patients with COVID-19